SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunex
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: nwtechman who wrote (200)3/12/1998 2:58:00 PM
From: LJM   of 656
 
If they get FDA Approval and get the drug on the market 4th Q, which is a lot of ifs.....we could see 100. One other positive, was the very upbeat interview with the CEO yesterday on CNBC. He could barely contain his excitement about the indications and seemed quite confident regarding 4 Q delivery, pending FDA approval. Even Mark Haines and Jim Kramer were impressed with the CEO's remarks, especially when he discussed the expanded patient population of 2 million prospects for rheumatoid arthritis. They were both extremely bummed when they lost the satellite connection at the end of the interview. At that point, they were discussing the positive indications from a new asthma drug they have in the pipeline, too. I am afraid to even think about how good this looks; I may jinx it. Hoping for FDA approval -- ASAP -- and a big climb up.

I would like to hear some other opinions from others who hold the stock.

LJM
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News